• nPEC for Dual-Loaded Liposome Analysis

  2026-08-31

  A 2025 Journal of Pharmaceutical Sciences study systematically compared methods for measuring encapsulation efficiency in liposomes carrying both hydrophilic and lipophilic drugs. Its validation of nanoparticle exclusion chromatography (nPEC) provides a practical, broadly applicable route for simultaneous analysis without extensive sample pretreatment.

• Panobinostat (LBH589) Research Workflows

  2026-08-31

  Panobinostat (LBH589) links broad HDAC inhibition to measurable chromatin, apoptotic, and extracellular-matrix phenotypes. This practical guide shows how to build cancer and scleral macrophage workflows around the compound while separating validated findings from optimization starting points.

• DIDS: From Chloride Transport to Metastatic States

  2026-08-30

  DIDS is more than a conventional chloride channel blocker: it is a broad mechanistic probe that can connect ion transport, mitochondrial stress, tumor-cell survival, and translational assay design. This article examines how DIDS can be used to interrogate prometastatic states while preserving appropriate controls for specificity, formulation, and biological interpretation.

• Pretomanid Inhibits Both TB Terminal Oxidases

  2026-08-29

  The reference study identifies the cytochrome bcc:aa3 and bd terminal oxidases as functional respiratory targets of pretomanid, also known as PA-824. Its genetic and chemical biology evidence supports rational combinations with telacebec and ND-011992 to improve bactericidal activity against replicating and antibiotic-tolerant Mycobacterium tuberculosis while limiting resistance emergence.

• GSK621: Reading AMPK in Immunometabolic Assays

  2026-08-28

  GSK621 is a potent AMPK agonist for resolving energy-sensing, autophagy, lipid metabolism, and leukemia-associated phenotypes. This article presents an assay-architecture framework that separates AMPK pathway activation from cell-state interpretation and connects AML findings with immunometabolic research.

• Vancomycin Workflows for Microbiome Research

  2026-08-28

  Learn how to deploy Vancomycin as a controlled bacterial cell wall perturbation tool in MRSA, resistance, and microbiome–immune experiments. This workflow-focused guide connects peptidoglycan precursor binding with practical culture assays, antibiotic-perturbation controls, and troubleshooting for immune readouts.

• Oseltamivir Acid: Assay-to-Model Translation

  2026-08-27

  Oseltamivir acid is an influenza neuraminidase inhibitor whose value depends on connecting enzyme inhibition with cellular, resistance, and translational readouts. This article presents an assay-to-model framework informed by humanized-mouse pharmacokinetic research, while clearly separating direct evidence from practical recommendations.

• Ethacridine lactate monohydrate in Cell Assays

  2026-08-27

  Ethacridine lactate monohydrate offers a practical microbial-control variable for sensitive stem-cell, chromatin, and biochemical workflows. Its aqueous and DMSO solubility support formulation screening, while compatibility controls help distinguish antiseptic effects from genuine YAP-TEAD and super-enhancer biology.

• Dual-Readout mRNA for Translational Delivery

  2026-08-26

  A mechanistic and strategic guide to using dual-fluorescence reporter mRNA to separate nanoparticle uptake from productive translation, strengthen assay design, and accelerate targeted mRNA delivery decisions.

• Tobramycin: From Ribosome Mechanism to Translation

  2026-08-26

  Tobramycin is more than an aminoglycoside antibiotic: it is a defined perturbation tool for studying bacterial protein synthesis, Gram-negative microbiology, and resistance phenotypes. This thought-leadership guide connects historical comparative evidence with practical assay design, product-selection considerations, and a disciplined translational outlook.

• Central Control of Opioid Mechanical Hypersensitivity

  2026-08-25

  A 2024 Neuron study identifies a lateral parabrachial nucleus–hypothalamus–spinal dorsal horn pathway that controls morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. Its findings separate mechanical opioid side effects from better-established thermal mechanisms and provide a circuit-level framework for testing μ-opioid receptor dependence.

• Iron Stress Reprograms Enterocyte Metabolism

  2026-08-25

  Navazesh and Ji show that both iron deficiency and iron excess produce distinct metabolic and transcriptional states in IPEC-J2 enterocytes. Their combination of bidirectional iron manipulation, inflammatory challenge, time-course gene analysis, and untargeted metabolomics provides a useful framework for studying how intestinal epithelial cells adapt to iron stress.

• MK-8745: Aurora A Inhibitor Workflow Guide

  2026-08-24

  MK-8745 is a potent, selective Aurora A inhibitor for connecting kinase inhibition with mitotic arrest, tetraploidy, and apoptosis in cancer models. This workflow guide covers formulation, cell-based assay design, non-Hodgkin lymphoma applications, retinoblastoma translation, and xenograft study planning.

• Torin2 Assay Design: Distinguishing Arrest From Death

  2026-08-24

  Torin2 is a potent mTOR inhibitor for dissecting growth arrest, cell killing, and pathway-dependent responses. This guide applies a measurement framework from Schwartz’s cancer-drug research to improve viability, apoptosis assay, and medullary thyroid carcinoma experiments.

• gamma-Glu-Cys (γ-Glu-Cys) Workflow Guide

  2026-08-23

  gamma-Glu-Cys (γ-Glu-Cys) provides a defined, soluble intermediate for glutathione synthetase enzyme assays, glutathione metabolism research, and selected peptide workflows. It is intended for controlled scientific research only, not diagnostic or medical use, and freshly prepared solutions should be used promptly.

8120 records 1/542 page Next 12345 下5页 Last page